News
PMN
1.230
-1.60%
-0.020
Weekly Report: what happened at PMN last week (0902-0906)?
Weekly Report · 09/09 11:45
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Barchart · 09/05 06:00
Weekly Report: what happened at PMN last week (0826-0830)?
Weekly Report · 09/02 11:49
ProMIS Neurosciences files to sell 56.51M common shares for holders
Seeking Alpha · 08/29 20:49
PROMIS NEUROSCIENCES INC FILES FOR RESALE FROM TIME TO TIME OF 56.5 MLN COMMON SHARES OF CO BY SELLING STOCKHOLDERS - SEC FILING
Reuters · 08/29 20:37
Weekly Report: what happened at PMN last week (0819-0823)?
Weekly Report · 08/26 11:46
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
Benzinga · 08/19 11:48
Weekly Report: what happened at PMN last week (0812-0816)?
Weekly Report · 08/19 11:30
Weekly Report: what happened at PMN last week (0805-0809)?
Weekly Report · 08/12 11:33
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Investorplace · 08/12 11:30
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/12 10:04
ProMIS Neurosciences GAAP EPS of -$0.13
Seeking Alpha · 08/09 14:10
Buy Rating on ProMIS Neurosciences Backed by Innovative Alzheimer’s Treatment and Strong Financials
TipRanks · 08/09 11:52
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q2 2024
Investorplace · 08/08 18:53
Based on the provided financial report articles, the title of the article is: "Form 10-Q for the quarterly period ended June 30, 2024
Press release · 08/08 13:30
ProMIS Neurosciences Reveals Data On The Pathogenic Role Of Toxic Misfolded SOD1 Aggregates In ALS
Benzinga · 08/06 11:07
GREAT POINT PARTNERS, LLC REPORTS 9.99% PASSIVE STAKE IN PROMIS NEUROSCIENCES INC AS OF JULY 26- SEC FILING
Reuters · 08/05 20:05
Weekly Report: what happened at PMN last week (0729-0802)?
Weekly Report · 08/05 11:45
Weekly Report: what happened at PMN last week (0722-0726)?
Weekly Report · 07/29 11:34
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 07/26 17:25
More
Webull provides a variety of real-time PMN stock news. You can receive the latest news about Promis Neuroscie through multiple platforms. This information may help you make smarter investment decisions.
About PMN
ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.